Eyeing the biotech IPO boom earlier this year, Ariosa Diagnostics planned to go public as it battled larger competitors in the prenatal testing field. But the San Jose, CA-based company backed off in late April, and that was its last chance. Multinational healthcare firm Roche has bought Ariosa for an undisclosed amount, the companies announced today.
{iframe}http://www.xconomy.com/san-francisco/2014/12/02/roche-enters-noninvasive-prenatal-test-market-with-ariosa-purchase/{/iframe}